A Case Report of Chemotherapy-Induced Hand-Foot Syndrome Treated with Modified Dohongsamul-tang |
Han, Ga-jin
(Soram Korean Medicine Hospital)
Jang, Myeong-woong (Soram Korean Medicine Hospital) Seong, Sin (Soram Korean Medicine Hospital) Kim, Sung-su (Soram Korean Medicine Hospital) |
1 | Abushullaih S, Saad ED, Munsell M, Hoff PM. Incidence and severity of hand-foot syndrome in colorectal cancer patients treated with capecitabine: a single-institution experience. Cancer Invest 2002; 20(1):3-10. DOI |
2 | Amy SC, Linda TV. Chemotherapy-induced palmar-plantar erythrodysesthesia syndrome: etiology and emerging therapies. Support Cancer Therapy 2004;1(4):213-8. DOI |
3 | Zhao C, Chen J, Yu B, Wu X, Dai C, Zhou C, et al. Effect of modified taohongsiwu decoction on patients with chemotherapy-induced hand-foot syndrome. J Tradit Chin Med 2014;34(1):10-4. DOI |
4 | Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management. Am J Clin Dermatol 2000; 1(4):225-34. DOI |
5 | Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991;24(3) :457-61. DOI |
6 | Azuma Y, Hata K, Sai K, Udagawa R, Hirakawa A, Tohkin M, et al. Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer. Biol Pharm Bull 2012;35(5):717-24. DOI |
7 | Wehler TC, Cao Y, Galle PR, Theobald M, Moehler M, Schimanski CC. Combination therapies with oxaliplatin and oral capecitabine or intravenous 5-FU show similar toxicity profiles in gastrointestinal carcinoma patients if hand-food syndrome prophylaxis is performed continuously. Oncol Lett 2012;3(6) :1191-4. DOI |
8 | von Gruenigen V, Frasure H, Fusco N, DeBernardo R, Eldermire E, Eaton S, et al. A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients. Cancer 2010;116(20):4735-43. DOI |
9 | Wolf SL, Qin R, Menon SP, Rowland KM Jr, Thomas S, Delaune R, et al. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced Hand-Foot Syndrome: North central cancer treatment group study N05C5. J Clin Oncol 2010;28(35):5182-7. DOI |
10 | National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.4.0, 2010. Available at http://evs.nci.nih.gov/ftp1/CTCAE/About.html) |
11 | Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359(4):378-90. DOI |
12 | McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 2015;19(2):223-38. DOI |
13 | Grandinetti CA, Goldspiel BR. Sorafenib and sunitinib: novel targeted therapies for renal cell cancer. Pharmacotherapy 2007;27(8):1125-44. DOI |
14 | Gridelli C, Maione P, Del Gaizo F, Colantuoni G, Guerriero C, Ferrara C, et al. Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer. Oncologist 2007;12(2):191-200. DOI |
15 | Lipworth AD, Robert C, Zhu AX. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology 2009;77(4):257-71. DOI |
16 | Oh G. Golden Mirror of Medicine. Seoul: Daesungmoonhwasa; 1983, p. 443. |
17 | Korean medicine pathological association. Pathology in Korean medicine. Seoul: Iljoongsa; 1998, p. 153, 165. |
18 | Korean Herbological Association. Herbology. Seoul: Younglimsa; 1992, p. 124-5, 193-6, 302-4, 334-5, 401-2, 409-10, 412-4, 423-6, 578-83. |
19 | Korean Dermatological Association. Detmatology. 3rd ed. Seoul: RyoMoonGak; 1994, p. 548. |
20 | Cho DI, Kim HS. The literature review for prescription of static blood. Daejeon University Korean Medicine Research Institute 1997;5(2) :265-79. |
21 | Jo SJ, ChoI YD, Jang JT, Kim KS, Lee SD. A Randomized Controlled Clinical Trial of Topical Herbal Gel Treatment for Chronic Shoulder Pain. The Acupuncture 2014;31(4):1-9. DOI |
22 | Yoo BS, Jung JE, Park JY, Yoon JM, Lee I, Moon BS. Protective Effects of Dohongsamul-tang on Zinc-mediated Cytotoxicity in H9c2 Cardiomyoblast Cells. JPPKM 2004;18(5): 1374-81. |
23 | Moon WS, Lee BW, Ahn SW, Kim EH. A Historical consideration on the External Treatment theories and diseases for which medicine is efficacious. Korean Journal of Oriental Medicine 2004;10(2):1-21. |
24 | Wang L, Jiao ZM, Li P. Traditional Chinese Medicine internal and external wash treatment for eight cases hand-foot syndrome caused by capecitabine. Zhong Yi Yan Jiu 2006;19(4):41-3. |
25 | Cho YL, Jung HW. The effect of DohongSamulTang (DST) on immune-system in L1210 cells-transplanted mice. JPPKM 1999;13(1):132-40. |
26 | Yook HS, Ahn SY, Doo HG. The Effects Of Geumguesingitang And Dohongsamultang On Rats With Nephrosis Induced By Puromycin Aminonucleoside. Journal of Korean Medicine 1997;18(2):283-315. |
27 | Shin DC, Kim YG. The Study on the Effect of Dohongsamultang and Dansameum on Restrain of Thorombus Formation. Korean J Orient Int Med 1995;16(2):136-45. |